T 1112/96 (Erythropoietin production/GENETICS INSTITUTE) of 19.10.1999
- European Case Law Identifier
- ECLI:EP:BA:1999:T111296.19991019
- Date of decision
- 19 October 1999
- Case number
- T 1112/96
- Petition for review of
- -
- Application number
- 86900439.0
- IPC class
- C12P 21/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method for the production of erythropoietin
- Applicant name
- Genetics Institute, Inc.
- Opponent name
- Janssen-Cilag GmbH
Hoechst Aktiengesellschaft
Johnson & Johnson
Elanex Pharmaceuticals Inc.
Merckle GmbH Chem.-pharm. Fabrik - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973
- Keywords
- Added subject-matter (no)
Novelty (yes)
Inventive step (yes) - Catchword
- -
- Cited cases
- T 0412/93
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the following documents:
(a) claims 1 to 7 submitted during oral proceedings as main request, and
(b) description: pages 3, 4, 13, 14, 34, 35 submitted during oral proceedings; and pages 5 to 12, 15 to 33. as granted, and
(c) drawings: Figures 1 to 4, 5A, 5A', 5B, 5B', 5C, 6 to 8 as granted.